Come up with a name for your new list and we'll add to it:
Prelude Therapeutics raised a round of funding on August 15, 2017. Investors include
Delaware Economic Development Office.
Prelude Therapeutics is a privately held biotechnology company focused on discovering and developing new medicines targeting chromatin function to treat cancer and rare diseases.…